Psychedelics Capital Moves: Beckley Waves Raises $3.3M, Clearmind's $2.25M Public Offering
Portfolio Pulse from Lara Goldstein
UK-based venture studio Beckley Waves has raised $3.3 million in a funding round to expand safe and legal access to psychedelic therapies. The round was oversubscribed by 10% and included participation from several family and VC mission-aligned offices. The funds will be used for strategic investments into selected early-stage teams. In other news, Israeli biotech company Clearmind Medicine (NASDAQ:CMND) is pricing its US-only public offering, expecting to raise approximately $2.25 million. The offering consists of 7.5 million common shares and pre-funded warrants, and 7.5 million common warrants.
September 15, 2023 | 4:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Clearmind Medicine is pricing its US-only public offering, expecting to raise approximately $2.25 million. The offering consists of 7.5 million common shares and pre-funded warrants, and 7.5 million common warrants.
The news of Clearmind Medicine's public offering is directly related to the company and its stock. However, the impact on the stock price is uncertain as it depends on the market's reaction to the offering. The offering could potentially dilute existing shares, but it could also provide the company with needed capital for growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100